Sun Pharmaceutical Industries has secured investment-grade ratings from Moody's and S&P for its proposed $11.75 billion ...
Biocon has signed a significant 10-year contract to supply pertuzumab, a breast cancer drug, in Brazil, emphasizing its ...
Novo Nordisk announces the termination of two heart drug trials for ziltivekimab, casting doubt on its diversification ...
Novartis' cholesterol drug pelacarsen fails to reduce heart attack and stroke risk in late-stage study, impacting investor ...
In a significant ruling, the Supreme Court of India has dismissed Sanofi's petition against a CBI complaint involving alleged procurement manipulation at Bhabha Atomic Research Centre from 2012 to ...
Roivant's experimental drug mosliciguat has demonstrated significant efficacy in treating pulmonary hypertension linked to lung disease, achieving primary and secondary trial goals, pushing shares up ...
New Zealand's health authorities have granted approval for the use of MDMA in treating severe PTSD, making it only the second country to do so. This move follows Australia's recent decision and ...
Novartis India has announced the acquisition of Pfizer's hypertension drug Minipress for ₹1250 crore, aiming to enhance its product portfolio while Pfizer navigates sales declines in the wake of COVID ...
HRV Pharma, based in Hyderabad, is set to invest ₹150 crore to enhance its peptide manufacturing capabilities and develop high-potency oncology APIs, aiming to meet industry demands for specialized ...
Novo Nordisk reports a significant reduction in obesity rates among children aged 6 to under 12 treated with semaglutide in a recent clinical trial, highlighting potential for systemic obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results